Other headlines

Augusztus 30, 2022
Az új AMD Socket AM5 platform a világ első 5 nm-es asztali PC processzoraival ...
Augusztus 29, 2022
Az ASBIS Group a 4PHONES cég partnerstandján mutatja be márkakínálatának ...
Augusztus 26, 2022
A vállalat folytatja adományozási tevékenységét a leginkább érintett ...
Augusztus 25, 2022
Az AMD bejelentette a "together we advance_PCs", a következő generációs AMD PC ...
Augusztus 16, 2022
Az adományként összegyűjtött teljes összeget C-íves röntgenkészülékek ...
Augusztus 01, 2022
The new version is providing users with additional tools to facilitate the ...
Július 25, 2022
ASBIS clients will now get access to IP Infusion’s leading networking software ...
Július 21, 2022
A harmadik negyedéves disztribútori pont promóció már elérhető!
Június 29, 2022
ASBIS will offer Edgecore’s networking solutions to its clients in the EMEA ...
Június 17, 2022
The vendor was noted in two categories for its security, compliance, and ...
ASBIS partners with IP Infusion in the EMEA region

Július 25, 2022

ASBIS, IP Infusion

ASBIS partners with IP Infusion in the EMEA region

ASBIS clients will now get access to IP Infusion’s leading networking software and solutions

In June 2022, value-added distributor ASBIS signed a distribution agreement with IP Infusion, further expanding its portfolio of networking solutions with industry-leading software products. The authorized area covers the EMEA region and includes all the 27 countries where ASBIS operates.

IP Infusion is a leading provider of open networking software and solutions for carriers, service providers, and data center operators. IP Infusion’s flagship OcNOS software is ranked as the industry’s Network Operating System (NOS) leader, enabling network operators to disaggregate their networks to accelerate innovation, streamline operations, and reduce Total Cost of Ownership (TCO).

Network OEMs may also disaggregate network devices to expedite time to market, offer comprehensive services, and achieve carrier-grade robustness. IP Infusion’s software is market mature with over 500 customers and over 10,000 carrier-grade deployments for aggregation, disaggregated cell site gateways, provider edge routing, optical transport networks, data center networking and more.

“This is a great addition to our portfolio of networking solutions, and this agreement will help us bring even more value to our clients across many regions. ASBIS is happy to welcome IP Infusion as its partner and we are ready to do our best for a mutually successful future!” - commented Marek Horyl, Product Marketing Director at ASBIS.

“We are pleased to partner with ASBIS in the EMEA market to extend our reach in the EMEA regions through ASBIS’ distribution channel,” said Tom Savoie, Chief Sales Officer for IP Infusion. “Together IP Infusion and ASBIS offer powerful disaggregated software solutions for our customers to receive the promise and benefits of open networking.”

 

About ASBIS

ASBISC Enterprises PLC (WSE: ASB) is a leading Value Add Distributor, OEM, and Solutions Provider of IT, IoT, IoT, and AI across CEE, FSU, and MEA. The company specializes in value-added distribution (VAD), B2B market solutions and ICT products distribution from global suppliers. As IT industry leaders, the Group’s expert teams configure hardware products and software elements, cloud-based services, and technologies to create commercially viable solutions of choice. For more information, visit the company's website at www.asbis.com.

About IP Infusion

IP Infusion is a leading provider of open network software and solutions for carriers, service providers and data center operators. Our solutions enable network operators to disaggregate their networks to accelerate innovation, streamline operations, and reduce Total Cost of Ownership (TCO). Network OEMs may also disaggregate network devices to expedite time to market, offer comprehensive services, and achieve carrier grade robustness. IP Infusion is headquartered in Santa Clara, Calif., and is a wholly owned and independently operated subsidiary of ACCESS CO., LTD. Additional information can be found at http://www.IPInfusion.com.

Nyilatkozat: Az oldalainkon közölt információk, közlemények a közzététel napján felelnek meg a valóságnak. A közétett információk, közlemények az oldalainkon folyamatosan elérhetőek maradnak, azonban a közzétételt követően nem tudjuk garantálni, hogy az esetlegesen bekövetkező változásoknak megfelelően frissítjük vagy töröljük a nem naprakész információkat. Ennek megfelelően semminemű felelősséget nem vállalunk azért, hogy a közzétételt követően az oldalainkon található információk pontosak maradnak.